Family Palliative and End-of-Life Care for Advanced Heart Failure
Primary Purpose
Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
FamPALcare
Sponsored by
About this trial
This is an interventional supportive care trial for Heart Failure NYHA Class III focused on measuring advanced heart failure, breathlessness, supportive care
Eligibility Criteria
Inclusion Criteria:
- Alert and consent to participate
- Able to read and understand English
- Advanced HF (NYHA III or IV), diagnosed by physician
Exclusion Criteria:
- Already received or are on a waiting list for a heart transplant or left ventricular assist device (LVAD)
- Diagnosed with a terminal illness or dementia, such as Alzheimer's disease
Sites / Locations
- West Virginia University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
FamPALcare
Standard Care
Arm Description
Standard Care plus FamPALcare
The standard care group will receive routine HF care and instruction at university hospital or at clinic appointments. All patients can be referred for supportive care and heart failure care per national HF guidelines.
Outcomes
Primary Outcome Measures
Patient HF health status
Change from baseline in patient-reported HF health status measured by Kansas City Cardiomyopathy Questionnaire (KCCQ) over 6 months. KCCQ is a 12-item Likert scale (range 0-4). Scores will be rescaled to 0-100, higher score indicates better HF health status.
Patient mental health - depression & anxiety
Change from baseline in patient-reported mental health measured by -item Likert Patient Health Questionnaire (PHQ-4) scale (range 0-3), higher score indicates poor mental health status.
Patient signed advance directive
increased numbers of signed advance directives
Caregiver mental health - depression & anxiety
Change from baseline in caregiver reported mental health measured by -item Likert Patient Health Questionnaire (PHQ-4) scale (range 0-3), higher score indicates poor mental health status.
Caregiver quality of life - physical and mental health
Change from baseline in caregiver reported physical and mental health measured by 12-item Likert SF12V2 Health Survey (PCS and MCS scores). Standardized scores will be calculated. Higher scores indicate better quality of life.
Caregiver burden
Change from baseline in caregiver-reported burden measured by 12-item Likert Short-form Caregiver Burden Interviews(range 0-4), higher score indicates poorer outcomes (more burden).
Patient and caregiver confidence in providing palliative home care for advanced HF
Change from baseline in patient- and caregiver-reported confidence in HF home care measured by 4-item Likert Confidence scale (range 1-4), higher score indicates higher confidence.
Patient and caregiver preparedness in providing palliative home care for advanced HF
Change from baseline in patient - and caregiver-reported preparedness in HF home care measured by 1-item Likert perceived preparedness question (range 0-4), high score indicates better preparedness.
Secondary Outcome Measures
Evaluate intervention helpfulness (patients and caregivers)
Evaluate intervention helpfulness by patients and caregiver via 11-item Likert helpfulness scale, high score indicates more helpfulness
Evaluate intervention helpfulness (healthcare professionals)
Evaluate intervention helpfulness by healthcare professionals via 8-item Likert helpfulness scale, high score indicates more helpfulness
Evaluate healthcare utilizations
Change from baseline in healthcare utilization (hospitalization, ER visits) via medical record review
Full Information
NCT ID
NCT04153890
First Posted
November 4, 2019
Last Updated
October 10, 2023
Sponsor
West Virginia University
Collaborators
National Institute of Nursing Research (NINR)
1. Study Identification
Unique Protocol Identification Number
NCT04153890
Brief Title
Family Palliative and End-of-Life Care for Advanced Heart Failure
Official Title
Coaching End-of-Life Palliative Care for End-Stage Heart Failure Patients and Their Family Caregivers in Rural Appalachia
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
January 13, 2020 (Actual)
Primary Completion Date
July 31, 2023 (Actual)
Study Completion Date
September 1, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
West Virginia University
Collaborators
National Institute of Nursing Research (NINR)
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Overall objective is to test whether the 5-weekly family home palliative and end-of-life care (FamPALcare) intervention educational and supportive sessions will improve rural home end-of-life and palliative care (EOLPC) for advanced heart failure at 6 months follow up.
Detailed Description
Heart failure (HF) afflicts 6.5 million Americans with devastating consequences to patients and their family caregivers especially during severe symptoms in the long-lasting end stage. Advanced HF was defined by American Heart Association (AHA) as "the presence of progressive and/or persistent severe signs and symptoms of HF despite optimized medical, surgical, and device therapy." When patients and family members are not prepared for worsening HF and are not informed about end-of-life and palliative care (EOLPC) conservative comfort options, they experience depression, fear of painful death, home care burden, and medical expenses from anxiously seeking aggressive but futile care. Notably, West Virginia (WV) has the highest HF death in the U.S. at 32.6 per 100,000 population, where 14% of those over 65 years have HF. WV is in the large Appalachian region, which stretches across eastern North America with 25.6 million people and contains a vast number of disadvantaged rural communities. National Institutes of Health has designated Appalachia as a high priority for research as residents experience extreme health and poverty inequities and limited access to healthcare. Furthermore, home EOLPC is lacking across this disadvantaged rural area. Thus, there is a need to investigate the new family intervention (FamPALcare), where nurses coach family-managed advanced HF care at home in Appalachia.
This study addresses the National Institutes of Health Academic Research Enhancement Award (AREA) priorities for conducting a low risk clinical trials to provide a foundation to advance scientific EOLPC knowledge and testing of our intervention efficacy in larger clinical trials. Additionally, effective EOLPC interventions are priorities of palliative care professionals and palliative care needs must be addressed with vulnerable and advanced HF patients and their families. This study also addresses the priority problem of the lack information for families providing advanced HF home care and preventing unwanted and unwarranted rehospitalizations at the advanced stage of HF.
This study uses a randomized controlled trial (RCT) design stratified by gender (male vs female) to determine any differences in the FamPALcare HF patients and their family caregiver outcomes versus standard care control group outcomes (N=72). Specific aims are to: (1) Test the FamPALcare nursing care intervention with patients and family members managing home supportive EOLPC for advanced HF in rural WV using a small randomized controlled trial (RCT) and (2) Assess implementation of the FamPALcare intervention and research procedures for subsequent clinical trials.
The control patients receive standard care given through the West Virginia University hospital and outpatient clinics, prescribed by the patient's cardiologist. The FamPALcare intervention group will receive standard care, plus 5-weekly FamPALcare intervention delivered by community-based nurses. FamPALcare intervention involves coaching patients and family caregivers in advanced HF home care and supporting EOLPC discussions. Data will be collected from all patients and caregivers independently at baseline, 3 months, and 6 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure NYHA Class III, Heart Failure NYHA Class IV
Keywords
advanced heart failure, breathlessness, supportive care
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study is a low-risk randomized control trial design to test the implementation of the FamPALcare intervention with advanced HF patients and their primary family caregivers.
Masking
Care ProviderOutcomes Assessor
Masking Description
Care provider and outcome assessor including data collectors will be blinded to group assignment.
Allocation
Randomized
Enrollment
78 (Actual)
8. Arms, Groups, and Interventions
Arm Title
FamPALcare
Arm Type
Experimental
Arm Description
Standard Care plus FamPALcare
Arm Title
Standard Care
Arm Type
No Intervention
Arm Description
The standard care group will receive routine HF care and instruction at university hospital or at clinic appointments. All patients can be referred for supportive care and heart failure care per national HF guidelines.
Intervention Type
Behavioral
Intervention Name(s)
FamPALcare
Intervention Description
Intervention participants will receive standard care plus five weekly coaching sessions with telephone follow-up to reinforce HF palliative home care. FamPALcare intervention will be delivered by community-based nurses. FamPALcare intervention involves coaching patients and family caregivers in advanced HF home care and supporting EOLPC discussions.
The standard care group will receive routine HF care and instruction at university hospital or at clinic appointments. All patients can be referred for supportive care and heart failure care per national HF guidelines.
Primary Outcome Measure Information:
Title
Patient HF health status
Description
Change from baseline in patient-reported HF health status measured by Kansas City Cardiomyopathy Questionnaire (KCCQ) over 6 months. KCCQ is a 12-item Likert scale (range 0-4). Scores will be rescaled to 0-100, higher score indicates better HF health status.
Time Frame
Through 6 months post baseline
Title
Patient mental health - depression & anxiety
Description
Change from baseline in patient-reported mental health measured by -item Likert Patient Health Questionnaire (PHQ-4) scale (range 0-3), higher score indicates poor mental health status.
Time Frame
Through 6 months post baseline
Title
Patient signed advance directive
Description
increased numbers of signed advance directives
Time Frame
Through 6 months post baseline
Title
Caregiver mental health - depression & anxiety
Description
Change from baseline in caregiver reported mental health measured by -item Likert Patient Health Questionnaire (PHQ-4) scale (range 0-3), higher score indicates poor mental health status.
Time Frame
Through 6 months post baseline
Title
Caregiver quality of life - physical and mental health
Description
Change from baseline in caregiver reported physical and mental health measured by 12-item Likert SF12V2 Health Survey (PCS and MCS scores). Standardized scores will be calculated. Higher scores indicate better quality of life.
Time Frame
Through 6 months post baseline
Title
Caregiver burden
Description
Change from baseline in caregiver-reported burden measured by 12-item Likert Short-form Caregiver Burden Interviews(range 0-4), higher score indicates poorer outcomes (more burden).
Time Frame
Through 6 months post baseline
Title
Patient and caregiver confidence in providing palliative home care for advanced HF
Description
Change from baseline in patient- and caregiver-reported confidence in HF home care measured by 4-item Likert Confidence scale (range 1-4), higher score indicates higher confidence.
Time Frame
Through 6 months post baseline
Title
Patient and caregiver preparedness in providing palliative home care for advanced HF
Description
Change from baseline in patient - and caregiver-reported preparedness in HF home care measured by 1-item Likert perceived preparedness question (range 0-4), high score indicates better preparedness.
Time Frame
Through 6 months post baseline
Secondary Outcome Measure Information:
Title
Evaluate intervention helpfulness (patients and caregivers)
Description
Evaluate intervention helpfulness by patients and caregiver via 11-item Likert helpfulness scale, high score indicates more helpfulness
Time Frame
Completed at 6 months
Title
Evaluate intervention helpfulness (healthcare professionals)
Description
Evaluate intervention helpfulness by healthcare professionals via 8-item Likert helpfulness scale, high score indicates more helpfulness
Time Frame
Completed at 6 months
Title
Evaluate healthcare utilizations
Description
Change from baseline in healthcare utilization (hospitalization, ER visits) via medical record review
Time Frame
Completed over 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Alert and consent to participate
Able to read and understand English
Advanced HF (NYHA III or IV), diagnosed by physician
Exclusion Criteria:
Already received or are on a waiting list for a heart transplant or left ventricular assist device (LVAD)
Diagnosed with a terminal illness or dementia, such as Alzheimer's disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ubolrat Piamjariyakul, PhD, RN
Organizational Affiliation
West Virginia University, School of Nursing
Official's Role
Principal Investigator
Facility Information:
Facility Name
West Virginia University Hospital
City
Morgantown
State/Province
West Virginia
ZIP/Postal Code
26506
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
The study plans to share data in aggregate and as overall study results.
Citations:
PubMed Identifier
31884945
Citation
Piamjariyakul U, Petitte T, Smothers A, Wen S, Morrissey E, Young S, Sokos G, Moss AH, Smith CE. Study protocol of coaching end-of-life palliative care for advanced heart failure patients and their family caregivers in rural appalachia: a randomized controlled trial. BMC Palliat Care. 2019 Dec 29;18(1):119. doi: 10.1186/s12904-019-0500-z.
Results Reference
derived
Learn more about this trial
Family Palliative and End-of-Life Care for Advanced Heart Failure
We'll reach out to this number within 24 hrs